Sinopharm Group (01099) said its net profit attributable to equity holders for the nine months ended 30 September 2016 rose 26.8% year-on-year to Rmb3,596 million.
Basic and diluted earnings per share were Rmb1.3.
Total operating revenue amounted to Rmb191,839.85 million, an increase of 12.97% from a year earlier.
【你點睇】五一黃金周逾75萬人訪港，不少遊客到「打卡位」體驗香港文化，你認為當局應如何推廣本港特色文化遊？► 立即投票
